RxDoctor Payments Data

Charles Bolno, DO

Family Medicine · Rockledge, PANPI 1427113349

Payments from drug & device makers

$12,637in general payments, 2019–2025

Across 882 payments — averaging $14.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • AstraZeneca$1K
  • GSK$954
  • Pfizer$935
  • Lilly USA, LLC$919
  • plus $5K from 45 others

What the payments were for

  • Food & beverage$12,632100%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,637 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$226,948
Medicare patients
246
Services billed
2,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$104,151
Taltz AutoinjectorIxekizumab13$87,683
EliquisApixaban73$55,481
TrulicityDulaglutide47$45,090
FarxigaDapagliflozin Propanediol53$36,283
Nurtec OdtRimegepant Sulfate15$26,755
OxycontinOxycodone Hcl11$23,016
XareltoRivaroxaban20$18,012
MounjaroTirzepatide16$16,946
WegovySemaglutide11$15,285
JanuviaSitagliptin Phosphate25$15,034
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,256
ArexvyRsvpref3 Antigen/As01e/Pf36$10,768
Tresiba Flextouch U-100Insulin Degludec17$9,508
Fiasp FlextouchInsulin Aspart (Niacinamide)16$8,252

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$715$119,436115 claims
PfizerEliquis, Nurtec Odt, Paxlovid$935$85,095100 claims
Lilly USA, LLCTrulicity, Mounjaro$919$62,03663 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,353$51,50677 claims
Johnson & JohnsonXarelto$81$18,01220 claims
MerckJanuvia$416$15,03425 claims
GSKArexvy, Shingrix$954$14,28653 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Rockledge

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →